ArticleSaudi medical journal2025
Trends in diabetes mellitus prevalence and gender disparities in Jazan, Saudi Arabia: A retrospective analysis.
Article in Saudi medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A cross-sectional survey on exploring adherence to diabetes treatment regimens: Insights from Hail region, Saudi Arabia.Medicine · 2026Article
- Biochanin A enhances wound healing in diabetic rats: emphasis on antioxidant, anti-inflammatory, angiogenic and pro-collagen activities.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Integrated UHPLC-QTOF-MSJournal of computer-aided molecular design · 2026Article
- Association Between Lifestyle Factors and the Prevalence of Non-Communicable Diseases in Saudi Adults Across Different Age Groups: A Cross-Sectional Study.Diseases (Basel, Switzerland) · 2026Article
- Community Prevalence and Predictors of Pelvic Floor-Related Symptoms in Saudi Men: Implications for Physiotherapy-Led Care.Healthcare (Basel, Switzerland) · 2026Article
- The rising burden of obesity-linked cancers in Saudi Arabia: a public health review.Annals of medicine and surgery (2012) · 2026Article
- Observational
- Developing count regression techniques for predicting the number of new type 2 diabetes cases in Saudi Arabia.PloS one · 2026Article
- Clinical efficacy, safety, and predictors of treatment response to SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a retrospective comparative study.Frontiers in endocrinology · 2026Article
- Molecular impact of single nucleotide polymorphisms in GIPR gene among type 2 diabetes mellitus patients in the Saudi population.Diabetology & metabolic syndrome · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo analyze the prevalence of DM focusing on demographic trends, gender disparities, and age distribution. Additionally, it evaluates diabetes control rates.
methodsA retrospective cross-sectional study examined DM trends (2021-2023). It included patients with type 1 or type 2 DM from various healthcare settings.
resultsThe number overall number of diabetes cases has grown from 41,876 in 2021 to 46,889 in 2023, reflecting an annual rise of 5.7% (2022) and 6% (2023). The majority of cases (85.1%) were observed in individuals aged 40 and above, having the greatest prevalence in the 50-59 age group (25.3%). A significant gender disparity was found, with 54.4% of cases occurring in males and 45.6% in females (χ²=355.539, degrees of freedom=1,
conclusionThe findings indicate a steady increase in DM prevalence in Jazan, with significant age and gender disparities. The study underscores the need for early screening programs, targeted lifestyle interventions, and improved diabetes management strategies to address the growing burden of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.